Trials / Unknown
UnknownNCT01679223
Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12
Objective Evaluation of Collagen Deposition in AlloMaxTM Acellular Dermal Matrix in Breast Reconstruction Version 8-15-12
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- University of Nevada, Las Vegas · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to measure the level of AlloMax™ incorporation (cellular infiltration, collagen production, and neovascularization) in human breast reconstruction. The hypothesis is that the AlloMaxTM will have incorporation equivalent to adjacent breast capsule at the 3-4 month time point.
Conditions
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2018-11-01
- Completion
- 2018-11-01
- First posted
- 2012-09-05
- Last updated
- 2015-01-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01679223. Inclusion in this directory is not an endorsement.